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Objective: To investigate the inﬂuence of morbid obesity on the lung age in women and to
correlate with body mass, body mass index (BMI), and ventilatory variables.
Methods: This was a cross-sectional study with 72 morbidly obese women and a control
group consisting of 37 normalweightwomen. The subjects performed a pulmonary function
test to determine lung age, and the results were correlated to anthropometric variables and
lung volumes.
Results: The morbidly obese group had signiﬁcantly higher lung age (50.1± 6.8 years) than
the control group (38.8± 11.4 years). There was no difference in chronological age between
groups. There was a signiﬁcant positive correlation among chronological age, body mass,
BMI, and lung age (r = 0.3647, 0.4182, and 0.3743, respectively). There was a negative cor-
relation among forced vital capacity (FVC), forced expiratory volume in one second (FEV1),
FEV1/FVC ratio, expiratory reserve volume (ERV), and lungage (r =−0.7565,−0.8769, -−0.2723,
and −0.2417, respectively).
Conclusion: Lung age is increased in morbidly obese women and is associated with increased
body mass and BMI.
© 2013 Elsevier Editora Ltda.
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Objetivo: Veriﬁcar a inﬂuência da obesidade mórbida na idade pulmonar de mulheres e
correlacionar comamassa corporal, índice demassa corporal (IMC) e variáveis ventilatórias.
Métodos: Estudo longitudinal realizado com 72 obesas mórbidas e grupo controle consti-
tuído de mulheres eutróﬁcas. As voluntárias realizaram um teste de func¸ão pulmonar para
determinac¸ão da idade pulmonar e os resultados foram correlacionados com as variáveis
antropométricas e volumes pulmonares.
 Study conducted at Universidade Metodista de Piracicaba, Piracicaba, SP, Brazil.
∗ Corresponding author: Rodovia do Ac¸úcar Km 156, Taquaral, Bloco 7, Sala 33, Piracicaba, SP, 13400-911, Brazil.
E-mail: empforti@unimep.br (E.M. Pazzianotto-Forti).
2255-4823 © 2013 Elsevier Editora Ltda.
Open access under CC BY-NC-ND license
Open access under CC BY-NC-ND license
266 rev assoc med bras . 2013;59(3):265–269
Resultados: As obesas mórbidas apresentaram uma idade pulmonar signiﬁcativamente
superior (50,1± 6,8 anos) às eutróﬁcas (38,8± 11,4 anos). Não houve diferenc¸a entre a idade
cronológica entre os grupos. Houve uma correlac¸ão signiﬁcativa e positiva entre idade
cronológica, massa corporal e IMC com a idade pulmonar (r = 0,3647, 0,4182, 0,3743, respec-
tivamente). Houve uma correlac¸ão negativa entre a capacidade vital forc¸ada (CVF), volume
expiratório forc¸ado no primeiro segundo (VEF1), razão (VEF1/CVF) e volume de reserva
expiratório (VRE) com a idade pulmonar (r =−0.7565, −0.8769, −0.2723, −0.2417, respectiva-
mente).
Conclusão: A idade pulmonar das obesas mórbidas encontra-se aumentada e está associada
com o aumento da massa corporal e IMC.
Introduction
According to the World Health Organization, obesity is con-
sidered a public health problem of alarming proportions
worldwide. It has been predicted for 2015 that approximately
2.3 billion adults will be overweight, and that over 700 million
will be obese.1 In Brazil, 48.5% of the population is overweight,
of which 15.8% is classiﬁed as obese.2
Obesity is considered a relevant risk factor for cardiovascu-
lar disease, diabetes mellitus type 2, rheumatoid arthritis, and
cancer.3–5 It is also recognized as an important risk factor for
developing respiratory diseases, such as hypoventilation syn-
drome and sleep apnea, as well as for the reduction in lung
volumes.6
Reports on changes in lung function in obesity point to
mechanical and inﬂammatory changes as major factors. The
inﬂammatory effects are due to the secretion of inﬂamma-
tory adipokines by adipose tissue. These adipokines regulate
the inﬂammatory system, which is associated with changes
in lung function.7,8 The mechanical effects are attributed to
increased abdominal pressure and decreased chest wall com-
pliance caused by excessive fat tissue in these regions.9,10
Equations were developed from linear regression to esti-
mate lung age, considering the ventilatory function obtained
through spirometry. Research has showed that forced expira-
tory volume in the ﬁrst second (FEV1) is the best variable for
mathematically calculating lung age11 in order to compare it
with the individual’s chronological age, as a marker for the
individual’s awareness of the dangers of smoking in studies
related to lung disease and smoking.12
Taking under consideration that the literature has few
studies of lung age in relation to obesity, while at the same
time many studies point to changes in lung function in this
population, the hypothesis of this study is thatmorbidly obese
women may have an early pulmonary aging compared to nor-
mal weight women.
Since morbid obesity leads to several comorbidities and
reduced quality of life, strategies must be designed to combat
this disease through awareness of its harm to health. Thus,
the aim of the present study was to investigate the inﬂuence
of morbid obesity in women’s lung age, and to correlate lung
age with body mass, BMI, and ventilatory variables.
Methods
Population studied
This was a cross-sectional study, in which 109 adult women
were studied, divided into two parallel groups: 72 obese
women (age: 34.6±6.8 years, BMI: 45.8± 5.4 kg/m2), and a con-
trol group of 37 normal weight women (age: 34.9± 7.6 years,
BMI: 22.7±1.9 kg/m2). Thevolunteerswere informedabout the
objective of the study and signed an informed consent. The
study was approved by the ethics committee under protocol n
19/10.
The morbidly obese women were screened in a bariatric
clinic in the city of Piracicaba, São Paulo, Brazil, where they
met with the multidisciplinary team to prepare for bariatric
surgery. The control group was recruited in the community by
invitation to participate in research.
The inclusion criteria were: women with morbid obe-
sity (40 kg/m2 ≤ BMI ≤ 55kg/m2) and normal weight women
(18.5 kg/m2 ≤ BMI ≤ 24.9 kg/m2); age between 25 and 50 years;
caucasian; sedentary with scores up to 8, according to the
Baecke Questionnaire,13 which was validated in Brazil by
Florida and Latorre;14 without the presence of comorbidities
such as hypertension, diabetes, cardiovascular or pulmonary
disease; nonsmokers or ex-smokers; and understanding of
spirometric maneuvers.
Procedures
Initially, data pertinent to the clinical history, anthropometry,
and assessment of lung volumes and capacities were per-
formed by spirometric test.
Anthropometrics data
The subjects stood without shoes or heavy clothes. Body
weight was measured by a digital scale (Filizola® – Brazil) cal-
ibrated with a maximum capacity of 300Kg, and resolution
of 100 grams. Height was assessed by a wall stadiome-
ter. The BMI was obtained by the equation weight/height2
(kg/m2).
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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Table 1 – Age, anthropometrics, and spirometric
characteristics of normal weight and morbidly obese
women.
Variables Normal weight
(n=37)
Morbidly
obese (n=72)
p-value
Chronological
age (years)
34.9±7.6 34.6± 6.8 0.58
Height (m) 1.6± 5.6 1.6±5.9 0.5751
Body weight (kg) 58.9±6.1 119.5±14.4 < 0.0001
BMI (kg/m2) 22.7±1.9 45.8± 5.4 < 0.05
FVC (L) 3.5± 0.4 3.28± 0.5 0.0076
FVC (% predicted) 103.1±9.6 96.0± 13.1 0.0023
VEF1 (L) 3.1± 0.4 2.8±0.4 0.0006
FEV1 (%
predicted)
106.8± 11.4 96.3± 12.3 < 0.0001
FEV11/FVC (%
predicted)
102.1± 7.0 100.1±6.3 0.03
ERV (L) 0.8± 0.3 0.5±0.4 0.0005
Values expressed as mean and standard deviation.
BMI, body mass index; FVC, forced vital capacity; FEV1, forced expi-
ratory volume in the ﬁrst second; FEV1/FVC, ratio of FEV1 to FVC;
ERV, expiratory reserve volume.
Spirometry
Spirometry was performed by computerized spirometer ultra-
sonic ﬂow sensor (Microquark, Cosmed – Rome, Italy),
calibrated daily before each test, following the standards
recommended by the American Thoracic Society15 and the
guidelines for testing lung function.16 All testswereperformed
in the morning to avoid circadian inﬂuences. The volunteers
were instructed to remain seated and to use a nose clip during
the maneuvers.
Slow vital capacity (SVC) and forced vital capacity (FVC)
maneuvers were performed. Time-volume and volume-ﬂow
curves were performed according to the criteria for accept-
ability and reproducibility recommended by the guidelines for
pulmonary function tests,16 in which the values for FEV1 and
FVC should differ less than 0.15 liters. Subsequently, it was
calculated the highest value of FVC and FEV1. The values were
expressed in liters and in percentage of predicted, according
to established values for the Brazilian population.17
Calculation of the estimated lung age
The calculation of lung age was based on estimates developed
by Newbury et al.11 (2010), which can be automatically gener-
ated by adjusting the settings of the spirometer, or calculated
following the mathematical formula:
Lung age = 1.33 × height (cm) − 31.98 × FEV1 obtained − 74.65
Statistical analysis
After verifying the normality of the data by Lilliefors test,
paired Student’s t-test for parametric data and Wilcoxon test
for nonparametric data were used to compare intra-group.
For comparison between groups, Student’s t-test for unpaired
parametric data and the Mann-Whitney test for nonparamet-
ric data were performed.
Table 2 – Comparison between pulmonary and
chronological age normal weight and morbidly obese
women.
Normal weight Morbidly obese p-value
Chronological
age (years)
34.9 ± 7.6 34.6 ± 6.8 0.58
Lung age (years) 38.8 ± 11.4 50.1 ± 14.2 < 0.0001
Lung age -
chronological
age
3.9 ± 12.3 15.5 ± 12.3 < 0.0001
Values expressed as mean and standard deviation.
Pearson’s correlation for parametric variables and the
Spearman correlation for nonparametric variables were used
for the correlation analysis of lung age with chronological age,
anthropometrics, and lung volume.
The level of statistical signiﬁcance was set at p < 0.05.
All statistical procedures were performed using the statistical
program BioStat version 5.0.
Results
There were no statistical differences in chronological age
between the groups (Table 1). Body weight and BMI were sig-
niﬁcantly higher in morbidly obese than in normal weight
women. Regarding spirometric values, it was observed that
FVC, FEV1, FVC/FEV1, and expiratory response volume (ERV)
were signiﬁcantly lower in the morbidly obese group.
There was no difference in chronological age between
groups (Table 2). The results of the comparison bet-
ween chronological age and lung age show a signiﬁcantly
higher lung age (50.1± 14.2 years) in themorbidly obese group,
with a difference of 15.5± 12.3 years. There was no differ-
ence between chronological age (34.6± 7.6 years) and lung age
(38.8±11.4 years) in the normal weight group.
Lung age was positively correlated to chronological age,
body mass and BMI (Table 3). Lung age was negatively cor-
related to obtained and predicted FVC, FEV1, FEV1/FVC ratio,
and ERV.
Table 3 – Correlation among lung age, pulmonary
volumes, and anthropometric data of morbidly obese
and normal weight women.
Lung age vs Coefﬁcient of correlation (r) p-value
Chronological age 0.3647 < 0.0001
Body weight (kg) 0.4182 < 0.0001
BMI (kg/m2) 0.3743 < 0.0001
FVC (L) −0.7565 < 0.0001
FVC (%P) −0.7449 < 0.0001
FEV1(L) −0.8769 < 0.0001
FEV1(%P) −0.8789 < 0.0001
FEV1/FVC (%P) −0.2723 0.0043
ERV (L) −0.2417 0.0117
Values expressed as mean and standard deviation.
BMI, body mass index; FVC, forced vital capacity obtained; FVC,
forced vital capacity; FEV1, forced expiratory volume in the ﬁrst sec-
ond; FEV1/FVC, ratio of FEV1 to FVC; ERV, expiratory reserve volume.
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Discussion
The concept of lung age was established with the objective of
becoming a tool of awareness of damages that smoking causes
to the lung, leading to premature aging of the organ. More
recently, the calculation of lung age has been validated for
detection of abnormalities caused by lung diseases.18 Parkes
et al.19 conducted a study with 561 smokers with age up to
35 years, and found that telling smokers their lung age sig-
niﬁcantly improved the probability of an individual to quit
smoking.
Studies show that obese subjects have higher levels of
biomarkers of oxidative stress. The chronic oxidative stress
in obesity promotes the development of organ lesions, such
as cardiovascular disease and airway changes with reduced
lung function.20
The measurement of lung age suggests an identiﬁcation of
the pulmonary impairment of individualswithmorbid obesity
before they present spirometric or respiratory disorders.
FEV1 is a powerful predictor of mortality and morbid-
ity in general, lung diseases, cardiovascular diseases, and
cancers.6 Studies show that weight gain is associated with
reduced FEV1 and vital capacity (VC), predisposing obese indi-
viduals to long-term adverse effects comparable to smoking,
respiratory infections, and occupational and environmental
exposures.21,22
However, although obesity is a known predictor of reduc-
tion in FEV1 and FVC and of increased lung age, an appropriate
program for losing excessweight not only improves lung func-
tion but also causes a reduction in lung age.23
Thus it is important to study the lung age ofmorbidly obese
with no signs of cardiac or pulmonary disease, and to educate
these individuals on the importance of weight loss, changes
in habits, and greater adherence to treatment seeking weight
reduction, before the installation of respiratory diseases that
may contribute to a worsening of health and quality of
life.
In the present study, an increased lung age of 11.3 years
was observed in morbidly obese women compared to normal
weight women; no difference was observed in chronological
and lung age in the normal weight group.
The formula used to predict the lung age in this study was
established by Newbury et al.,11 whose study aimed to com-
pare the lungageof a groupof 340nonsmokers and50 smokers
with the original formula established by Morris and Temple.12
Newbury et al.11 found that the formula established by Mor-
ris underestimated the lung age of smokers and nonsmokers
in approximately two decades, and thus proposed the new
formula.
Melo et al.24 also found an increase of almost a decade in
lung age in the morbidly obese group, even though they used
the formula by Morris and Temple .12
Pulmonary aging related to obesitywas also observed in the
study by Mitsumune et al.,25 which investigated the relation-
ship among lung age, cigarette smoking, and BMI, and veriﬁed
that a higher BMI was signiﬁcantly associated with older lung
age, regardless of cigarette addiction. However, in their study,
obese people were considered as those with a BMI equal to or
greater than 25kg/m2, according to the classiﬁcation of obesity
by the Japanese Respiratory Society, which differs from that of
the World Health Organization.
In the present study, there was a positive correlation
between lung age and chronological age. As age increases,
structural changes occur in the lung parenchyma and airways,
as well as in the rib cage and respiratory muscles. There is an
increase in FVC and FEV1 until approximately age 20 years for
women, and it diminishes with age, declining around 20mL
per year in subjects aged 25 to 39 years. This decline occurs
gradually up to 65 years, when a reduction of around 38mL
per year begins.26
In thepresent study, therewas apositive correlation among
lung age, body mass, and BMI. A correlation of lung age with
BMI was also observed by Melo et al.24 With exception of
this last study, the association between aging of the lung and
anthropometrics variables was not found in the literature.
Most studies have sought to relate anthropometric variables
and lung volumes, thus the importance of the present study
for people with morbid obesity is emphasized.
There was a signiﬁcant negative correlation between lung
age and ERV. Moreover, this variable was found reduced com-
pared with the control group. Regarding pulmonary function,
it is well known that the greatest predictor of obesity is due
to the reduction of ERV, leading to a reduction in functional
residual capacity (FRC). This is due to cranial displacement of
the diaphragm by abdominal obesity and weight gain of the
chest wall. ERV reduces exponentially increasing BMI.27
The concept of lung age,whenadded to spirometric results,
is a new alternative understanding of lung damage caused
by obesity, and provides a simple, easy, and straightforward
interpretation. For obese patients, the calculation of lung age
can be an instrument to promote greater adherence to weight
loss programs, since the results of spirometry may not be well
understood.24
It can be concluded that the lung age observed in the
morbidly obese group gives increased evidence of early lung
aging in this population, and it is associated with increased
body mass and BMI. The calculation of lung age can be rec-
ommended for morbidly obese patients to demonstrate the
pulmonary complications of obesity, to motivate changes in
lifestyle, and to emphasize the need for programs of weight
reduction.
Conﬂict of interest
The authors declare to have no conﬂict of interest. The date
of approval of the Ethics and Research, Methodist University
of Piracicaba was 27/04/2010, under No. 19/10.
Acknowledgements
The authors would like to thank National Council for Sci-
entiﬁc and Technological Development (Conselho Nacional
de Desenvolvimento Cientíﬁco e Tecnológico - CNPq), and
Coordination for the Improvement of Higher Level Personnel
(Coordenac¸ão de Aperfeic¸oamento de Pessoal de Nível Supe-
rior - CAPES/PROSUP) for their contribution and support.
rev assoc med bras . 2013;59(3):265–269 269
r e f e r enc e s
1. WHO. World Health Organization. Obesity and overweight.
2006 [cited 2011 Mar 20]. Available from: http://www.who.int/
mediacentre/factsheets/fs311/en/
2. Brasil. Ministério da Saúde. Doenc¸as ligadas à obesidade
custam R$ 488 milhões [cited 22 Mar 2013]. Available from:
http://portalsaude.saude.gov.br/portalsaude/noticia/9905/
162/doencas-associadas-a-obesidade-custam-meio-bilhao-
de-reais.html
3. McClean KM, Kee F, Young IS, Elborn JS. Obesity and the lung:
epidemiology. Thorax. 2008;637:649–54.
4. Murugan AT, Sharma G. Obesity and respiratory diseases.
Chronic Respir Dis. 2008;5:233–42.
5. Conway B, Rene A. Obesity as a disease: no lightweight
matter. Obesity Reviews. 2004;5:145–51.
6. Knuiman MW, James AL, Divitini ML, Musk AW, Ryan G,
Bartholomew HC. Lung function respiratory symptoms and
mortality: results from the Busselton Health Study. Annals
of Epidemiology. 1999;9:297–306.
7. Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM.
Systemic inﬂammation and decline in lung function in a
general population: a prospective study. Thorax.
2007;62:515–20.
8. Thyagarajan B, Smith LJ, Barr RG, Sood A, Kalhan R, Jacobs Jr
DR. Association of circulating adhesion molecules with lung
function: The CARDIA Study. Chest. 2009;135:1481–7.
9. Collins CL, Hoberty PD, Walker JF, Fletcher EC, Peiris AN. The
effects of body fat distribution on pulmonary function tests.
Chest. 1995;107:1298–302.
10. Forti E, Ike D, Barbalho-Moulim M, Rasera JRI, Costa D. Effects
of chest physiotherapy on the respiratory function of
postoperative gastroplasty patients. Clinics. 2009;64:683–9.
11. Newbury W, Newbury J, Briggs N, Crockett A. Exploring the
need to update lung age equations. Prim Care Respir J.
2010;13:242–7.
12. Morris JF, Temple W, Spirometric. lung age” estimation
for motivating smoking cessation. Preventive Medicine.
1985;14:655–62.
13. Baecke JA, Burema J, Frijters JE. A short questionnaire for the
measurement of habitual physical activity in epidemiological
studies. American Journal of Clinical Nutrition.
1982;36:936–42.
14. Florindo AA, Latorre MRDO. Validac¸ão do questionário e
reprodutibilidade de Baecke de avaliac¸ão da atividade física
habitual em homens adultos. Rev Bras Med Esporte.
2003:121–8.
15. ATS/ERS., Task Force. Standardisation of lung function
testing. Standardisation of spirometry. European Respiratory
Journal. 2005;26:319–38.
16. Pereira CAC. Directives for pulmonary function tests.
J Pneumol. 2002;28:1–82.
17. Pereira CAC, Barreto SP, Simões JG, Pereira FWL, Gerstler JG,
Nakamura J. Valores de referência para espirometria em uma
amostra da populac¸ão brasileira adulta. J Pneumol.
1992;18:10–22.
18. Toda R, Hoshino T, Kawayama T, Imaoka H, Sakazaki Y, Tsuda
T, et al. Validation of “lung age” measured by spirometry and
handy electronic FEV1/FEV6 meter in pulmonary diseases.
Internal Medicine. 2009;48:513–21.
19. Parkes G, Greenhalgh T, Grifﬁn M, Dent R. Effect on smoking
quit rate of telling patients their lung age: the Step2quit
randomised controlled trial. BMJ. 2008;336:598–600.
20. Fitzpatrick A, Holguin F. Obesity, asthma, and oxidative
stress. Journal of Applied Physiology. 2010;108:754–9.
21. Bottai M, Pistelli F, Di Pede F, Carrozzi L, Baldacci S, Matteelli
G, et al. Longitudinal changes of body mass index, spirometry
and diffusion in a general population. European Respiratory
Journal. 2002;20:665–73.
22. Womack CJ, Harris DL, Katzel LI, Katzel LI, Hagberg JM,
Bleecker ER, et al. Weight loss not aerobic exercise. Improves
pulmonary function in older obese men. Journals of
Gerontology Series A, Biological Sciences and Medical
Sciences. 2000;55:453–7.
23. Quanjer PH, Enrigh PL. Should we use ‘lung age’? Prim Care
Respir J. 2010;19:197–9.
24. Melo SMD, De Melo VA, De Melo EV, Menezes Filho RS, De
Castro VL, Barreto MSP. Accelerated lung aging in patients
with morbid obesity. J Bras Pneumol. 2010;36:746–52.
25. Mitsumune T, Senoh E, Nishikawa H, Adachi M, Kajii E. The
effect of obesity and smoking status on lung age in Japanese
men. Respirology. 2009;14:757–60.
26. Janssens JP, Pache JC, Nicod LP. Physiological changes in
respiratory function associated with ageing. European
Respiratory Journal. 1999;13:197–205.
27. Jones RL, Nzekwu MMU. The effects of body mass index
on lung volumes. Chest. 2006;130:827–33.
